Cargando…
Supraphysiological activation of TAK1 promotes skeletal muscle growth and mitigates neurogenic atrophy
Skeletal muscle mass is regulated through coordinated activation of multiple signaling pathways. TAK1 signalosome has been found to be activated in various conditions of muscle atrophy and hypertrophy. However, the role and mechanisms by which TAK1 regulates skeletal muscle mass remain less understo...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9033787/ https://www.ncbi.nlm.nih.gov/pubmed/35459245 http://dx.doi.org/10.1038/s41467-022-29752-0 |
_version_ | 1784692975190671360 |
---|---|
author | Roy, Anirban Kumar, Ashok |
author_facet | Roy, Anirban Kumar, Ashok |
author_sort | Roy, Anirban |
collection | PubMed |
description | Skeletal muscle mass is regulated through coordinated activation of multiple signaling pathways. TAK1 signalosome has been found to be activated in various conditions of muscle atrophy and hypertrophy. However, the role and mechanisms by which TAK1 regulates skeletal muscle mass remain less understood. Here, we demonstrate that supraphysiological activation of TAK1 in skeletal muscle of adult mice stimulates translational machinery, protein synthesis, and myofiber growth. TAK1 causes phosphorylation of elongation initiation factor 4E (eIF4E) independent of mTOR. Inactivation of TAK1 disrupts neuromuscular junction morphology and causes deregulation of Smad signaling. Using genetic approaches, we demonstrate that TAK1 prevents excessive loss of muscle mass during denervation. TAK1 favors the nuclear translocation of Smad4 and cytoplasmic retention of Smad6. TAK1 is also required for the phosphorylation of eIF4E in denervated skeletal muscle. Collectively, our results demonstrate that TAK1 supports skeletal muscle growth and prevents neurogenic muscle atrophy in adult mice. |
format | Online Article Text |
id | pubmed-9033787 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-90337872022-04-28 Supraphysiological activation of TAK1 promotes skeletal muscle growth and mitigates neurogenic atrophy Roy, Anirban Kumar, Ashok Nat Commun Article Skeletal muscle mass is regulated through coordinated activation of multiple signaling pathways. TAK1 signalosome has been found to be activated in various conditions of muscle atrophy and hypertrophy. However, the role and mechanisms by which TAK1 regulates skeletal muscle mass remain less understood. Here, we demonstrate that supraphysiological activation of TAK1 in skeletal muscle of adult mice stimulates translational machinery, protein synthesis, and myofiber growth. TAK1 causes phosphorylation of elongation initiation factor 4E (eIF4E) independent of mTOR. Inactivation of TAK1 disrupts neuromuscular junction morphology and causes deregulation of Smad signaling. Using genetic approaches, we demonstrate that TAK1 prevents excessive loss of muscle mass during denervation. TAK1 favors the nuclear translocation of Smad4 and cytoplasmic retention of Smad6. TAK1 is also required for the phosphorylation of eIF4E in denervated skeletal muscle. Collectively, our results demonstrate that TAK1 supports skeletal muscle growth and prevents neurogenic muscle atrophy in adult mice. Nature Publishing Group UK 2022-04-22 /pmc/articles/PMC9033787/ /pubmed/35459245 http://dx.doi.org/10.1038/s41467-022-29752-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Roy, Anirban Kumar, Ashok Supraphysiological activation of TAK1 promotes skeletal muscle growth and mitigates neurogenic atrophy |
title | Supraphysiological activation of TAK1 promotes skeletal muscle growth and mitigates neurogenic atrophy |
title_full | Supraphysiological activation of TAK1 promotes skeletal muscle growth and mitigates neurogenic atrophy |
title_fullStr | Supraphysiological activation of TAK1 promotes skeletal muscle growth and mitigates neurogenic atrophy |
title_full_unstemmed | Supraphysiological activation of TAK1 promotes skeletal muscle growth and mitigates neurogenic atrophy |
title_short | Supraphysiological activation of TAK1 promotes skeletal muscle growth and mitigates neurogenic atrophy |
title_sort | supraphysiological activation of tak1 promotes skeletal muscle growth and mitigates neurogenic atrophy |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9033787/ https://www.ncbi.nlm.nih.gov/pubmed/35459245 http://dx.doi.org/10.1038/s41467-022-29752-0 |
work_keys_str_mv | AT royanirban supraphysiologicalactivationoftak1promotesskeletalmusclegrowthandmitigatesneurogenicatrophy AT kumarashok supraphysiologicalactivationoftak1promotesskeletalmusclegrowthandmitigatesneurogenicatrophy |